Rapamycin serves as an effective and specific inhibitor of the mammalian target of rapamycin (mTOR), disrupting the formation of foam cells by blocking mTOR activation, thereby impeding atherosclerosis progression.[91d] To enhance the therapeutic efficacy, Zhang et al. Here, MTOR is linked to atherosclerosis.